How the COG is Approaching the High-Risk Patient with ALL: Incorporation of Immunotherapy into Frontline Treatment.

Autor: Gupta S; Hospital for Sick Children and University of Toronto, 555 University Ave, Toronto, ON, M5G 1X8, Canada., Maude SL; Children's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, 3501 Civic Center Blvd, Philadelphia, PA, 19104, United States., O'Brien MM; Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, 3333 Burnet Ave, Cincinnati, OH, 45229, United States., Rau RE; Baylor College of Medicine, Texas Children's Hospital, 1102 Bates Street, Houston, TX, 77030, United States., McNeer JL; University of Chicago Comer Children's Hospital, 5841 S Maryland Ave, Chicago, IL, 60637, United States. Electronic address: jmcneer@peds.bsd.uchicago.edu.
Jazyk: angličtina
Zdroj: Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2020 Sep; Vol. 20 Suppl 1, pp. S8-S11.
DOI: 10.1016/S2152-2650(20)30443-2
Databáze: MEDLINE